Join our daily newsletter At The Bell to receive exclusive market insights
- Health technology company InteliCare (ICR) has entered a trading halt before it launches a capital raise
- InteliCare is an aged care and health technology company whose products help seniors and people with disabilities live at home independently
- It recently added to its product suite by launching InteliCare Health Metrics which helps users record data to manage their wellbeing and detect emerging health issues
- At this stage, it isn’t clear how much InteliCare will raise or what it will use the money for
- But the market will only have to wait until Thursday, April 29, at the latest
- InteliCare last traded at 28.5 cents on Monday, April 26
InteliCare (ICR) has entered a trading halt before it launches a capital raise.
The company expects it will remain in a trading halt until Thursday, April 29, unless details of the raise are announced earlier.
At this stage, it isn’t clear how much InteliCare will raise or what it will use the money for.
InteliCare is an aged care and health technology company whose products help seniors and people with disabilities live at home independently.
InteliLiving uses smart home sensors to learn the individual’s routine and sends daily messages about conditions and activity within the home.
Whereas, InteliCare Pro is a larger-scale software-as-a-service offering for care providers or hospitals. It connects to InteliLiving and allows residents to be monitored at the same time.
Most recently, the company launched a new product. InteliLiving Health Metrics helps users capture and record health data to manage their wellbeing and detect emerging health issues.
The product is available through both manual and automated methods or through smart health tracking devices like a Fitbit.
InteliCare last traded at 28.5 cents on Monday, April 26.
